Skip to Main Content

Paper Details

Epitope editing enables targeted immunotherapy of acute myeloid leukaemia.
Nature
15
2023
Acute myeloid leukaemia, B, B cell acute lymphoblastic leukaemia, CAR, CAR T cell, CD123, CD19, CD34, CD34 HSPCs, FLT3, HSPCs, KIT, acute myeloid leukaemia, amino acid, chimeric antigen receptor, chimeric antigen receptor (CAR) T cells, differentiated myeloid cells, epitope, genes, haematopoietic lineages, haematopoietic stem/progenitor cells, leukaemia, patient, tumour
Author NameAffiliation
Jerome RitzBoston Children's Hospital
Jerome RitzHarvard Medical School
Jerome RitzDana-Farber Cancer Institute
Daniel E BauerBoston Children's Hospital
Daniel E BauerHarvard Medical School
Daniel E BauerDana-Farber Cancer Institute
Scott A ArmstrongBoston Children's Hospital
Scott A ArmstrongDana-Farber Cancer Institute
Scott A ArmstrongHarvard Medical School
Scott A ArmstrongBoston Children's Hospital
Scott A ArmstrongDana-Farber Cancer Institute
Scott A ArmstrongHarvard Medical School
  • 1 - 12

Datasets

Release 1.2